Crucial role of vitamin D in the musculoskeletal system

Nutrients

Volumn 8, Issue 6, 2016, Pages

  Wintermeyer, Elke ^a   Ihle, Christoph ^a   Ehnert, Sabrina ^a   Stöckle, Ulrich ^a   Ochs, Gunnar ^a   de Zwart, Peter ^a   Flesch, Ingo ^a   Bahrs, Christian ^a   Nussler, Andreas K ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Bone health; Chronic disease; Muscle pain; Supplementation; Vitamin D; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; VITAMIN D;

BONE DENSITY; BONE STRENGTH; DUAL ENERGY X RAY ABSORPTIOMETRY; FALLING; HUMAN; META ANALYSIS (TOPIC); MUSCULOSKELETAL DISEASE; MUSCULOSKELETAL PAIN; OSTEOMALACIA; OSTEOPENIA; PREVALENCE; PRIMARY OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RICKETS; SARCOPENIA; SECONDARY OSTEOPOROSIS; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION; BONE DISEASES; DIETARY SUPPLEMENT; METABOLISM;

BONE DISEASES; DIETARY SUPPLEMENTS; HUMANS; MUSCULOSKELETAL PAIN; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84971378768     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8060319     Document Type: Review

References (133)

1. Funk, C. On the chemical nature of the substance which cures polyneuritis in birds induced by a diet of polished rice. J. Physiol. 1911, 43, 395-400
2. Lund, J.; Deluca, H.F. Biologically active metabolite of vitamin D3 from bone liver and blood serum. J. Lipid. Res. 1966, 7, 739-744
3. Deluca, H.F. History of the discovery of vitamin D and its active metabolites. Bonekey Rep. 2014, 3, 479
4. Wacker, M.; Holick, M.F. Vitamin D-Effects on skeletal and extraskeletal health and the need for supplementation. Nutrients 2013, 5, 111-148
5. Gendelman, O.; Itzhaki, D.; Makarov, S.; Bennun, M.; Amital, H. A randomized double-blind placebo-controlled study adding high dose vitamin D to analgesic regimens in patients with musculoskeletal pain. Lupus 2015, 24, 483-489
6. Heath, K.M.; Elovic, E.P. Vitamin D deficiency-Implications in the rehabilitation setting. Am. J. Phys. Med. Rehab. 2006, 85, 916-923
7. Shinchuk, L.; Holick, M.F. Vitamin D and rehabilitation: Improving functional outcomes. Nutr. Clin. Pract. 2007, 22, 297-304
8. Munns, C.F.; Shaw, N.; Kiely, M.; Specker, B.L.; Thacher, T.D.; Ozono, K.; Michigami, T.; Tiosano, D.; Mughal, M.Z.; Makitie, O.; et al. Global consensus recommendations on prevention and management of nutritional rickets. J. Clin. Endocrinol. Metab. 2016, 101, 394-415
9. Zhang, R.H.; He, D.H.; Zhou, B.; Zhu, Y.B.; Zhao, D.; Huang, L.C.; Ding, G.Q. Analysis of vitamin D status in men highly exposed to sunlight. Biomed. Environ. Sci. 2015, 28, 913-916
10. Holick, M.F. Vitamin D: A d-lightful solution for health. J. Invest. Med. 2011, 59, 872-880
11. Knutsen, K.V.; Brekke, M.; Gjelstad, S.; Lagerlov, P. Vitamin D status in patients with musculoskeletal pain, fatigue and headache: A cross-sectional descriptive study in a multi-ethnic general practice in Norway. Scand. J. Prim. Health 2010, 28, 166-171
12. Reuss-Borst, M.A. Metabolic bone disease osteomalacia. Z. Rheumatol. 2014, 73, 316-322
13. Barvencik, F.; Amling, M. Vitamin D metabolism of the bone. Orthopade 2015, 44, 686-694
14. Mutt, S.J.; Hypponen, E.; Saarnio, J.; Jarvelin, M.R.; Herzig, K.H. Vitamin D and adipose tissue-More than storage. Front. Physiol. 2014, 5, 228
15. Sutton, A.L.M.; MacDonald, P.N. Vitamin D: More than a “bone-a-fide” hormone. Mol. Endocrinol. 2003, 17, 777-791
16. Ritter, C.S.; Brown, A.J. Direct suppression of Pth gene expression by the vitamin D prohormones doxercalciferol and calcidiol requires the vitamin D receptor. J. Mol. Endocrinol. 2011, 46, 63-66
17. George, J.; Ganesh, H.K.; Acharya, S.; Bandgar, T.R.; Shivane, V.; Karvat, A.; Bhatia, S.J.; Shah, S.; Menon, P.S.; Shah, N. Bone mineral density and disorders of mineral metabolism in chronic liver disease. World J. Gastroenterol. 2009, 15, 3516-3522
18. Lavi-Moshayoff, V.; Wasserman, G.; Meir, T.; Silver, J.; Naveh-Many, T. Pth increases fgf23 gene expression and mediates the high-fgf23 levels of experimental kidney failure: A bone parathyroid feedback loop. Am. J. Physiol. Renal. 2010, 299, F882-F889
19. Christensen, M.H.; Apalset, E.M.; Nordbo, Y.; Varhaug, J.E.; Mellgren, G.; Lien, E.A. 1,25-dihydroxyvitamin D and the vitamin D receptor gene polymorphism apa1 influence bone mineral density in primary hyperparathyroidism. PLoS ONE 2013, 8, e56019
20. Tejwani, V.; Qian, Q. Calcium regulation and bone mineral metabolism in elderly patients with chronic kidney disease. Nutrients 2013, 5, 1913-1936
21. Choudhary, N.S.; Tomar, M.; Chawla, Y.K.; Bhadada, S.K.; Khandelwal, N.; Dhiman, R.K.; Duseja, A.; Bhansali, A. Hepatic osteodystrophy is common in patients with noncholestatic liver disease. Dig. Dis. Sci. 2011, 56, 3323-3327
22. Servier Medical Art. Powerpoint Image Bank. Available online: http://www.servier.com/Powerpoint--image-bank (accessed on 17 May 2016).
23. Ceglia, L. Vitamin D and its role in skeletal muscle. Curr. Opin. Clin. Nutr. 2009, 12, 628-633
24. Umhau, J.C.; George, D.T.; Heaney, R.P.; Lewis, M.D.; Ursano, R.J.; Heilig, M.; Hibbeln, J.R.; Schwandt, M.L. Low vitamin D status and suicide: A case-control study of active duty military service members. PLoS ONE 2013, 8, e51543
25. Takahashi, N.; Udagawa, N.; Suda, T. Vitamin D endocrine system and osteoclasts. Bonekey Rep. 2014, 3, 495
26. Carey, R.M.; Siragy, H.M. The intrarenal rennin-angiotensin system and diabetic nephropathy. Trends Endocrinol. Met. 2003, 14, 274-281
27. Williams, S.; Malatesta, K.; Norris, K. Vitamin D and chronic kidney disease. Ethn. Dis. 2009, 19, As8-As11.
28. Putz-Bankuti, C.; Pilz, S.; Stojakovic, T.; Scharnagl, H.; Pieber, T.R.; Trauner, M.; Obermayer-Pietsch, B.; Stauber, R.E. Association of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease. Liver Int. 2012, 32, 845-851
29. Li, Y.C. Renoprotective effects of vitamin D analogs. Kidney Int. 2010, 78, 134-139
30. Callegari, E.T.; Reavley, N.; Garland, S.M.; Gorelik, A.; Wark, J.D.; Team, S.-D.S. Vitamin D status, bone mineral density and mental health in young Australian women: The safe-D study. J. Public Health Res. 2015, 4, 152-156
31. Huang, J.Y.; Arnold, D.; Qiu, C.F.; Miller, R.S.; Williams, M.A.; Enquobahrie, D.A. Association of serum vitamin D with symptoms of depression and anxiety in early pregnancy. J. Womens Health 2014, 23, 588-595
32. Shuler, F.D.; Wingate, M.K.; Moore, G.H.; Giangarra, C. Sports health benefits of vitamin D. Sports Health 2012, 4, 496-501
33. Masood, T.; Kushwaha, R.S.; Singh, R.; Sailwal, S.; Pandey, H.; Varma, A.; Singh, R.K.; Cornelissen, G. Circadian rhythm of serum 25 (OH) vitamin D, calcium and phosphorus levels in the treatment and management of type-2 diabetic patients. Drug Discov. Ther. 2015, 9, 70-74
34. Looker, A.C.; Johnson, C.L.; Lacher, D.A.; Pfeiffer, C.M.; Schleicher, R.L.; Sempos, C.T. Vitamin D status: United States, 2001-2006. NCHS Data Brief 2011, 59, 1-8
35. Rabenberg, M.; Scheidt-Nave, C.; Busch, M.A.; Rieckmann, N.; Hintzpeter, B.; Mensink, G.B.M. Vitamin D status among adults in Germany-Results from the German health interview and examination survey for adults (DEGS1). BMC Public Health 2015, 15
36. Amling, M. Calcium and vitamin D in bone metabolism. Clinical importance for fracture treatment. Unfallchirurg 2015, 118, 995-999
37. Gilchrest, B.A. Sun exposure and vitamin D sufficiency. Am. J. Clin. Nutr. 2008, 88, 570S-577S
38. El-Sonbaty, M.R.; Abdul-Ghaffar, N.U. Vitamin D deficiency in veiled Kuwaiti women. Eur. J. Clin. Nutr. 1996, 50, 315-318
39. Diamond, T.H.; Levy, S.; Smith, A.; Day, P. High bone turnover in muslim women with vitamin D deficiency. Med. J. Aust. 2002, 177, 139-141
40. Allali, F.; el Aichaoui, S.; Saoud, B.; Maaroufi, H.; Abouqal, R.; Hajjaj-Hassouni, N. The impact of clothing style on bone mineral density among post menopausal women in Morocco: A case-control study. BMC Public Health 2006, 6
41. Metcalfe, D. The pathophysiology of osteoporotic hip fracture. Mcgill J. Med. 2008, 11, 51-57
42. Rader, C.P.; Corsten, N.; Rolf, O. Osteomalacia and vitamin D deficiency. Orthopade 2015, 44, 695-702
43. Bischoff-Ferrari, H.A.; Dawson-Hughes, B.; Staehelin, H.B.; Orav, J.E.; Stuck, A.E.; Theiler, R.; Wong, J.B.; Egli, A.; Kiel, D.P.; Henschkowski, J. Fall prevention with supplemental and active forms of vitamin D: A meta-analysis of randomised controlled trials. Br. Med. J. 2009, 339, 843-846
44. Vernazza, P.; Stoliaroff, A.; Boggian, K.; Schlegel, M. Vitamin D Substitution. Available online: https: //www.guidelines.ch/page/pdf/53 (accessed on 17 May 2016).
45. DVO Leitlinie Osteoporose 2014 Kurzfassung und Langfassung. Available online: http://www.dv--osteologie.org/uploads/Leitlinie%202014/DVO--Leitlinie%20Osteoporose%202014%20Kurzfassung%20und%20Langfassung%20Version%201a%2012%2001%202016.pdf (accessed on 17 May 2016).
46. Gesundes Altern: Höhere Vitamin-D Dosis Kann Sturzrisiko Erhöhen. Available online: http://www.aerzteblatt.de/nachrichten/65299/Gesundes--Altern--Hoehere--Vitamin--D--Dosis--kann--Sturzrisiko--erhoehen (accessed on 17 May 2016).
47. Sharifi, N.; Amani, R.; Hajiani, E.; Cheraghian, B. Women may respond different from men to vitamin D supplementation regarding cardiometabolic biomarkers. Exp. Biol. Med. 2016
48. O’Riordan, J.L.H.; Bijvoet, O.L.M. Rickets before the discovery of vitamin D. Bone Key Rep. 2014
49. Bivins, R. Ideology and disease identity: The politics of rickets, 1929-1982. Med. Humanit. 2014, 40, 3-10
50. Dunn, P.M. Sir robert hutchison (1871-1960) of London and the causes and treatment of rickets. Arch. Dis. Child. Fetal 2005, 90, F537-F539
51. Goldacre, M.; Hall, N.; Yeates, D.G.R. Hospitalisation for children with rickets in England: A historical perspective. Lancet 2014, 383, 597-598
52. Fukumoto, S.; Ozono, K.; Michigami, T.; Minagawa, M.; Okazaki, R.; Sugimoto, T.; Takeuchi, Y.; Matsumoto, T. Pathogenesis and diagnostic criteria for rickets and osteomalacia-proposal by an expert panel supported by the ministry of health, labour and welfare, Japan, the Japanese society for bone and mineral research, and the Japan endocrine society. J. Bone Miner. Metab. 2015, 33, 467-473
53. Lopresti, M.; Daolio, P.A.; Rancati, J.M.; Ligabue, N.; Andreolli, A.; Panella, L. Rehabilitation of a patient receiving a large-resection hip prosthesis because of a phosphaturic mesenchymal tumor. Clin. Pract. 2015, 5, 99-103
54. Arantes, H.P.; Gimeno, S.G.; Chiang, A.Y.; Bilezikian, J.P.; Lazaretti-Castro, M. Incidence of vertebral fractures in calcium and vitamin D-supplemented postmenopausal Brazilian women with osteopenia or osteoporosis: Data from arzoxifene generations trial. Arch. Endocrinol. Metab. 2016, 60, 54-59
55. Siris, E.; Adler, R.; Bilezikian, J.; Bolognese, M.; Dawson-Hughes, B.; Favus, M.; Harris, S.; Jan de Beur, S.; Khosla, S.; Lane, N.; et al. The clinical diagnosis of osteoporosis: A position statement from the national bone health alliance working group. Osteoporo. Int. 2014, 25, 1439-1443
56. Yoo, J.H.; Moon, S.H.; Ha, Y.C.; Lee, D.Y.; Gong, H.S.; Park, S.Y.; Yang, K.H. Osteoporotic fracture: 2015 position statement of the Korean society for bone and mineral research. J. Bone Metab. 2015, 22, 175-181
57. Shane, E.; Burr, D.; Ebeling, P.R.; Abrahamsen, B.; Adler, R.A.; Brown, T.D.; Cheung, A.M.; Cosman, F.; Curtis, J.R.; Dell, R.; et al. Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the American society for bone and mineral research. J. Bone Miner. Res. 2010, 25, 2267-2294
58. Jackson, R.D.; LaCroix, A.Z.; Gass, M.; Wallace, R.B.; Robbins, J.; Lewis, C.E.; Bassford, T.; Beresford, S.A.; Black, H.R.; Blanchette, P.; et al. Calcium plus vitamin D supplementation and the risk of fractures. N. Engl. J. Med. 2006, 354, 669-683
59. Johnell, O.; Kanis, J.A. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporosis. Int. 2006, 17, 1726-1733
60. Rode, A.; Fourlanos, S.; Nicoll, A. Oral vitamin D replacement is effective in chronic liver disease. Gastroenterol. Clin. Biol. 2010, 34, 618-620
61. Robert-Koch-Institut. Prävalenz von Osteoporose; Robert-Koch-Institut: Berlin, Germany, 2009; pp. 97-99.
62. Servier Medical Art. Bone Structure. Available online: http://www.servier.com/slidekit/?item=2 (accessed on 17 May 2016).
63. Winzenberg, T.; van der Mei, I.; Mason, R.S.; Nowson, C.; Jones, G. Vitamin D and the musculoskeletal health of older adults. Aust. Fam. Physician 2012, 41, 92-99
64. Bischoff-Ferrari, H.A.; Willett, W.C.; Orav, E.J.; Lips, P.; Meunier, P.J.; Lyons, R.A.; Flicker, L.; Wark, J.; Jackson, R.D.; Cauley, J.A.; et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N. Engl. J. Med. 2012, 367, 40-49
65. Bischoff-Ferrari, H.A.; Dawson-Hughes, B.; Baron, J.A.; Burckhardt, P.; Li, R.; Spiegelman, D.; Specker, B.; Orav, J.E.; Wong, J.B.; Staehelin, H.B.; et al. Calcium intake and hip fracture risk in men and women: A meta-analysis of prospective cohort studies and randomized controlled trials. Am. J. Clin. Nutr. 2007, 86, 1780-1790
66. Cummings, S.R.; Kiel, D.P.; Black, D.M. Vitamin D supplementation and increased risk of falling: A cautionary tale of vitamin supplements retold. JAMA Intern. Med. 2016, 176, 171-172
67. Huo, Y.R.; Suriyaarachchi, P.; Gomez, F.; Curcio, C.L.; Boersma, D.; Muir, S.W.; Montero-Odasso, M.; Gunawardene, P.; Demontiero, O.; Duque, G. Phenotype of osteosarcopenia in older individuals with a history of falling. J. Am. Med. Dir. Assoc. 2015, 16, 290-295
68. Kim, M.K.; Baek, K.H.; Song, K.H.; Kang, M., 2nd; Park, C.Y.; Lee, W.Y.; Oh, K.W. Vitamin D deficiency is associated with sarcopenia in older Koreans, regardless of obesity: The fourth Korea national health and nutrition examination surveys (KNHANES IV) 2009. J. Clin. Endocr. Metab. 2011, 96, 3250-3256
69. Snijder, M.B.; van Schoor, N.M.; Pluijm, S.M.F.; van Dam, R.M.; Visser, M.; Lips, P. Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J. Clin. Endocr. Metab. 2006, 91, 2980-2985
70. Pike, J.W. Closing in on vitamin D action in skeletal muscle: Early activity in muscle stem cells? Endocrinology 2016, 157, 48-51
71. Campbell, W.W.; Johnson, C.A.; McCabe, G.P.; Carnell, N.S. Dietary protein requirements of younger and older adults. Am. J. Clin. Nutr. 2008, 88, 1322-1329
72. De Koning, E.J.; van Schoor, N.M.; Penninx, B.W.J.H.; Elders, P.J.M.; Heijboer, A.C.; Smit, J.H.; Bet, P.M.; van Tulder, M.W.; den Heijer, M.; van Marwijk, H.W.J.; et al. Vitamin D supplementation to prevent depression and poor physical function in older adults: Study protocol of the D-vitaal study, a randomized placebo-controlled clinical trial. BMC Geriatr. 2015, 15
73. Bischoff-Ferrari, H.A.; Dawson-Hughes, B.; Orav, E.J.; Staehelin, H.B.; Meyer, O.W.; Theiler, R.; Dick, W.; Willett, W.C.; Egli, A. Monthly high-dose vitamin D treatment for the prevention of functional decline: A randomized clinical trial. JAMA Intern. Med. 2016, 176, 175-183
74. McCabe, P.S.; Pye, S.R.; Mc Beth, J.; Lee, D.M.; Tajar, A.; Bartfai, G.; Boonen, S.; Bouillon, R.; Casanueva, F.; Finn, J.D.; et al. Low vitamin D and the risk of developing chronic widespread pain: Results from the european male ageing study. BMC Musculoskelet. Dis. 2016, 17
75. Compston, J.E. Hepatic osteodystrophy-Vitamin-D metabolism in patients with liver-disease. Gut 1986, 27, 1073-1090
76. Mounach, A.; Ouzzif, Z.; Wariaghli, G.; Achemlal, L.; Benbaghdadi, I.; Aouragh, A.; Bezza, A.; el Maghraoui, A. Primary biliary cirrhosis and osteoporosis: A case-control study. J. Bone Miner. Metab. 2008, 26, 379-384
77. Arteh, J.; Narra, S.; Nair, S. Prevalence of vitamin D deficiency in chronic liver disease. Digest. Dis. Sci. 2010, 55, 2624-2628
78. Xiao, X.; Wang, Y.; Hou, Y.; Han, F.; Ren, J.; Hu, Z. Vitamin D deficiency and related risk factors in patients with diabetic nephropathy. J. Int. Med. Res. 2016
79. Ehnert, S.; Freude, T.; Ihle, C.; Mayer, L.; Braun, B.; Graeser, J.; Flesch, I.; Stockle, U.; Nussler, A.K.; Pscherer, S. Factors circulating in the blood of type 2 diabetes mellitus patients affect osteoblast maturation-Description of a novel in vitro model. Exp. Cell Res. 2015, 332, 247-258
80. Nussler, A.K.; Wildemann, B.; Freude, T.; Litzka, C.; Soldo, P.; Friess, H.; Hammad, S.; Hengstler, J.G.; Braun, K.F.; Trak-Smayra, V.; et al. Chronic CCl4 intoxication causes liver and bone damage similar to the human pathology of hepatic osteodystrophy: A mouse model to analyse the liver-bone axis. Arch. Toxicol. 2014, 88, 997-1006
81. Haug, A.T.; Braun, K.F.; Ehnert, S.; Mayer, L.; Stockle, U.; Nussler, A.K.; Pscherer, S.; Freude, T. Gene expression changes in cancellous bone of type 2 diabetics: A biomolecular basis for diabetic bone disease. Langenbeck Arch. Surg. 2014, 399, 639-647
82. Hochrath, K.; Ehnert, S.; Ackert-Bicknell, C.L.; Lau, Y.; Schmid, A.; Krawczyk, M.; Hengstler, J.G.; Dunn, J.; Hiththetiya, K.; Rathkolb, B.; et al. Modeling hepatic osteodystrophy in Abcb4 deficient mice. Bone 2013, 55, 501-511
83. Bu, F.X.; Armas, L.; Lappe, J.; Zhou, Y.; Gao, G.M.; Wang, H.W.; Recker, R.; Zhao, L.J. Comprehensive association analysis of nine candidate genes with serum 25-hydroxy vitamin D levels among healthy caucasian subjects. Hum. Genet. 2010, 128, 549-556
84. Jones, G. Expanding role for vitamin D in chronic kidney disease: Importance of blood 25-OH-D levels and extra-renal 1 alpha-hydroxylase in the classical and nonclassical actions of 1 alpha,25-dihydroxyvitamin D-3. Semin. Dial. 2007, 20, 316-324
85. Vujosevic, S.; Borozan, S.; Radojevic, N.; Aligrudic, S.; Bozovic, D. Relationship between 25-hydroxyvitamin D and newly diagnosed type 2 diabetes mellitus in postmenopausal women with osteoporosis. Med. Princ. Pract. 2014, 23, 229-233
86. Hogler, W.; Baumann, U.; Kelly, D. Endocrine and bone metabolic complications in chronic liver disease and after liver transplantation in children. J. Pediatr. Gastr. Nutr. 2012, 54, 313-321
87. Maalouf, N.M.; Sakhaee, K. Treatment of osteoporosis in patients with chronic liver disease and in liver transplant recipients. Curr. Treat. Options Gastroenterol. 2006, 9, 456-463
88. Yurci, A.; Kalkan, A.O.; Ozbakir, O.; Karaman, A.; Torun, E.; Kula, M.; Baskol, M.; Gursoy, S.; Yucesoy, M.; Bayram, F. Efficacy of different therapeutic regimens on hepatic osteodystrophy in chronic viral liver disease. Eur. J. Gastroenterol. Hepatol. 2011, 23, 1206-1212
89. Neyestani, T.R.; Nikooyeh, B.; Kalayi, A.; Zahedirad, M.; Shariatzadeh, N. A vitamin D-calcium-fortified yogurt drink decreased serum PTH but did not affect osteocalcin in subjects with type 2 diabetes. Int. J. Vitam. Nutr. Res. 2015, 85, 61-69
90. Wariaghli, G.; Allali, F.; el Maghraoui, A.; Hajjaj-Hassouni, N. Osteoporosis in patients with primary biliary cirrhosis. Eur. J. Gastroenterol. Hepatol. 2010, 22, 1397-1401
91. Guanabens, N.; Pares, A. Management of osteoporosis in liver disease. Clin. Res. Hepatol. Gastroenterol. 2011, 35, 438-445
92. Rudic, J.S.; Giljaca, V.; Krstic, M.N.; Bjelakovic, G.; Gluud, C. Bisphosphonates for osteoporosis in primary biliary cirrhosis. Cochrane Database Syst. Rev. 2011
93. Luxon, B.A. Bone disorders in chronic liver diseases. Curr. Gastroenterol. Rep. 2011, 13, 40-48
94. Spencer, H.; Rubio, N.; Rubio, E.; Indreika, M.; Seitam, A. Chronic alcoholism. Frequently overlooked cause of osteoporosis in men. Am. J. Med. 1986, 80, 393-397
95. Diamond, T.; Stiel, D.; Posen, S. Osteoporosis in hemochromatosis: Iron excess, gonadal deficiency, or other factors? Ann. Intern. Med. 1989, 110, 430-436
96. Diamond, T.H.; Stiel, D.; Lunzer, M.; McDowall, D.; Eckstein, R.P.; Posen, S. Hepatic osteodystrophy. Static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease. Gastroenterology 1989, 96, 213-221
97. Diamond, T.; Stiel, D.; Lunzer, M.; Wilkinson, M.; Posen, S. Ethanol reduces bone formation and may cause osteoporosis. Am. J. Med. 1989, 86, 282-288
98. Diamond, T.; Stiel, D.; Lunzer, M.; Wilkinson, M.; Roche, J.; Posen, S. Osteoporosis and skeletal fractures in chronic liver disease. Gut 1990, 31, 82-87
99. Guanabens, N.; Pares, A.; Marinoso, L.; Brancos, M.A.; Piera, C.; Serrano, S.; Rivera, F.; Rodes, J. Factors influencing the development of metabolic bone disease in primary biliary cirrhosis. Am. J. Gastroenterol. 1990, 85, 1356-1362
100. Gonzalez-Calvin, J.L.; Garcia-Sanchez, A.; Bellot, V.; Munoz-Torres, M.; Raya-Alvarez, E.; Salvatierra-Rios, D. Mineral metabolism, osteoblastic function and bone mass in chronic alcoholism. Alcohol Alcohol. 1993, 28, 571-579
101. Kayath, M.J.; Dib, S.A.; Vieira, J.G.H. Prevalence and magnitude of osteopenia associated with insulin-dependent diabetes-mellitus. J. Diabetes Complicat. 1994, 8, 97-104
102. Lindor, K.D.; Janes, C.H.; Crippin, J.S.; Jorgensen, R.A.; Dickson, E.R. Bone disease in primary biliary cirrhosis: Does ursodeoxycholic acid make a difference? Hepatology 1995, 21, 389-392
103. Monegal, A.; Navasa, M.; Guanabens, N.; Peris, P.; Pons, F.; de Osaba, M.J.M.; Rimola, A.; Rodes, J.; Munoz-Gomez, J. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif. Tissue Int. 1997, 60, 148-154
104. Sinigaglia, L.; Fargion, S.; Fracanzani, A.L.; Binelli, L.; Battafarano, N.; Varenna, M.; Piperno, A.; Fiorelli, G. Bone and joint involvement in genetic hemochromatosis: Role of cirrhosis and iron overload. J. Rheumatol. 1997, 24, 1809-1813
105. Kayath, M.J.; Tavares, E.F.; Dib, S.A.; Vieira, J.G.H. Prospective bone mineral density evaluation in patients with insulin-dependent diabetes mellitus. J. Diabetes Complicat. 1998, 12, 133-139
106. Gunczler, P.; Lanes, R.; Paz-Martinez, V.; Martinis, R.; Esaa, S.; Colmenares, V.; Weisinger, J.R. Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally. J. Pediatr. Endocr. Met. 1998, 11, 413-419
107. Angulo, P.; Therneau, T.M.; Jorgensen, A.; DeSotel, C.K.; Egan, K.S.; Dickson, E.R.; Hay, J.E.; Lindor, K.D. Bone disease in patients with primary sclerosing cholangitis: Prevalence, severity and prediction of progression. J. Hepatol. 1998, 29, 729-735
108. Gallego-Rojo, F.J.; Gonzalez-Calvin, J.L.; Munoz-Torres, M.; Mundi, J.L.; Fernandez-Perez, R.; Rodrigo-Moreno, D. Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 1998, 28, 695-699
109. Pollak, R.D.; Karmeli, F.; Eliakim, R.; Ackerman, Z.; Tabb, K.; Rachmilewitz, D. Femoral neck osteopenia in patients with inflammatory bowel disease. Am. J. Gastroenterol. 1998, 93, 1483-1490
110. Kemink, S.A.; Hermus, A.R.; Swinkels, L.M.; Lutterman, J.A.; Smals, A.G. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology. J. Endocrinol. Investig. 2000, 23, 295-303
111. Ardizzone, S.; Bollani, S.; Bettica, P.; Bevilacqua, M.; Molteni, P.; Porro, G.B. Altered bone metabolism in inflammatory bowel disease: There is a difference between crohn’s disease and ulcerative colitis. J. Intern. Med. 2000, 247, 63-70
112. Duarte, M.P.; Farias, M.L.; Coelho, H.S.; Mendonca, L.M.; Stabnov, L.M.; do Carmod Oliveira, M.; Lamy, R.A.; Oliveira, D.S. Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease. J. Gastroenterol. Hepatol. 2001, 16, 1022-1027
113. Menon, K.V.; Angulo, P.; Weston, S.; Dickson, E.R.; Lindor, K.D. Bone disease in primary biliary cirrhosis: Independent indicators and rate of progression. J. Hepatol. 2001, 35, 316-323
114. Kim, S.; Koga, T.; Isobe, M.; Kern, B.E.; Yokochi, T.; Chin, Y.E.; Karsenty, G.; Taniguchi, T.; Takayanagi, H. Stat1 functions as a cytoplasmic attenuator of runx2 in the transcriptional program of osteoblast differentiation. Genes Dev. 2003, 17, 1979-1991
115. Sokhi, R.P.; Anantharaju, A.; Kondaveeti, R.; Creech, S.D.; Islam, K.K.; van Thiel, D.H. Bone mineral density among cirrhotic patients awaiting liver transplantation. Liver Transpl. 2004, 10, 648-653
116. Jahnsen, J.; Falch, J.A.; Mowinckel, P.; Aadland, E. Bone mineral density in patients with inflammatory bowel disease: A population-based prospective two-year follow-up study. Scand. J. Gastroenterol. 2004, 39, 145-153
117. Floreani, A.; Mega, A.; Camozzi, V.; Baldo, V.; Plebani, M.; Burra, P.; Luisetto, G. Is osteoporosis a peculiar association with primary biliary cirrhosis? World J. Gastroenterol. 2005, 11, 5347-5350
118. Auletta, M.; Nuzzo, V.; Esposito, A.; Antonello, S.; Lupoli, G.; Federico, F.; de Puente, A. Osteoporosis in men: A study in patients affected by chronic non-advanced liver disease. Clin. Cases Miner. Bone Metab. 2005, 2, 25-28.
119. Guggenbuhl, P.; Deugnier, Y.; Boisdet, J.F.; Rolland, Y.; Perdriger, A.; Pawlotsky, Y.; Chales, G. Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos Int. 2005, 16, 1809-1814
120. Zali, M.; Bahari, A.; Firouzi, F.; Daryani, N.E.; Aghazadeh, R.; Emam, M.M.; Rezaie, A.; Shalmani, H.M.; Naderi, N.; Maleki, B.; et al. Bone mineral density in Iranian patients with inflammatory bowel disease. Int. J. Colorectal Dis. 2006, 21, 758-766
121. Hofmann, W.P.; Kronenberger, B.; Bojunga, J.; Stamm, B.; Herrmann, E.; Bucker, A.; Mihm, U.; von Wagner, M.; Zeuzem, S.; Sarrazin, C. Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon alpha and ribavirin therapy. J. Viral Hepat. 2008, 15, 790-796
122. Lumachi, F.; Camozzi, V.; Tombolan, V.; Luisetto, G. Bone mineral density, osteocalcin, and bone-specific alkaline phosphatase in patients with insulin-dependent diabetes mellitus. Ann. N. Y. Acad. Sci. 2009, 1173, E64-E67
123. Malik, P.; Gasser, R.W.; Kemmler, G.; Moncayo, R.; Finkenstedt, G.; Kurz, M.; Fleischhacker, W.W. Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: A cross-sectional study. Alcohol. Clin. Exp. Res. 2009, 33, 375-381
124. Goral, V.; Simsek, M.; Mete, N. Hepatic osteodystrophy and liver cirrhosis. World J. Gastroenterol. 2010, 16, 1639-1643
125. Loria, I.; Albanese, C.; Giusto, M.; Galtieri, P.A.; Giannelli, V.; Lucidi, C.; di Menna, S.; Pirazzi, C.; Corradini, S.G.; Mennini, G.; et al. Bone disorders in patients with chronic liver disease awaiting liver transplantation. Transplant. Proc. 2010, 42, 1191-1193
126. Wariaghli, G.; Mounach, A.; Achemlal, L.; Benbaghdadi, I.; Aouragh, A.; Bezza, A.; el Maghraoui, A. Osteoporosis in chronic liver disease: A case-control study. Rheumatol. Int. 2010, 30, 893-899
127. Wibaux, C.; Legroux-Gerot, I.; Dharancy, S.; Boleslawski, E.; Declerck, N.; Canva, V.; Mathurin, P.; Pruvot, F.R.; Cortet, B. Assessing bone status in patients awaiting liver transplantation. Jt. Bone Spine 2011, 78, 387-391
128. Angulo, P.; Grandison, G.A.; Fong, D.G.; Keach, J.C.; Lindor, K.D.; Bjornsson, E.; Koch, A. Bone disease in patients with primary sclerosing cholangitis. Gastroenterology 2011, 140, 180-188
129. Vargas, A.A.; Pascasio Acevedo, J.M.; Domingo, I.G.; Jimenez, R.G.; Martin, J.M.S.; Rios, M.T.F.; Mota, M.S.; Gallego, A.G.; Bravo, M.A.G. Prevalence and characteristics of bone disease in cirrhotic patients under evaluation for liver transplantation. Transplant. Proc. 2012, 44, 1496-1498
130. Pardee, P.E.; Dunn, W.; Schwimmer, J.B. Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children. Aliment. Pharmacol. Ther. 2012, 35, 248-254
131. Bruckner, G.L.; Grobholz, S.; Bruckner, T.; Scheidt-Nave, C.; Nawroth, P.; Schneider, J.G. Prevalence and determinants of osteoporosis in patients with type 1 and type 2 diabetes mellitus. BMC Endocr. Disord. 2014, 14, 33
132. Mathen, P.G.; Thabah, M.M.; Zachariah, B.; Das, A.K. Decreased bone mineral density at the femoral neck and lumbar spine in south Indian patients with type 2 diabetes. J. Clin. Diagn. Res. 2015, 9, OC8-OC12
133. Chinnaratha, M.A.; Chaudhary, S.; Doogue, M.; McCormick, R.J.; Woodman, R.J.; Wigg, A.J. Prevalence of hepatic osteodystrophy and vitamin D deficiency in cirrhosis. Intern. Med. J. 2015, 45, 1230-1235